Phenotype
|
Fish
|
Conditions
|
Figures
|
whole organism irf7 expression increased amount, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 1
from Danilova et al., 2018
|
embryo development arrested, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 6
from Danilova et al., 2018
|
whole organism ptgs2a expression increased amount, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 3
from Danilova et al., 2018
|
whole organism tlr1 expression increased amount, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 1,
Fig. 2
from Danilova et al., 2018
|
whole organism isg15 expression increased amount, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 1
from Danilova et al., 2018
|
whole organism stat1b expression increased amount, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 1
from Danilova et al., 2018
|
whole organism cfb expression increased amount, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 5
from Danilova et al., 2018
|
whole organism mmp9 expression increased amount, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 3
from Danilova et al., 2018
|
whole organism decreased length, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 6
from Danilova et al., 2018
|
whole organism tlr9 expression increased amount, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 2
from Danilova et al., 2018
|
eye decreased size, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 6
from Danilova et al., 2018
|
post-vent region kinked, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 6
from Danilova et al., 2018
|
whole organism fn1b expression increased amount, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 3
from Danilova et al., 2018
|
whole organism decreased life span, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 6
from Danilova et al., 2018
|
whole organism socs3b expression increased amount, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 1
from Danilova et al., 2018
|
trunk curved, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 6
from Danilova et al., 2018
|
whole organism cfh expression increased amount, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 5
from Danilova et al., 2018
|
whole organism il6 expression increased amount, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 3
from Danilova et al., 2018
|
whole organism inha expression decreased amount, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 4
from Danilova et al., 2018
|
whole organism ifih1 expression increased amount, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 2
from Danilova et al., 2018
|
whole organism socs3a expression increased amount, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 1
from Danilova et al., 2018
|
whole organism smad7 expression increased amount, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 4
from Danilova et al., 2018
|
whole organism c6.1 expression increased amount, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 5
from Danilova et al., 2018
|
whole organism fsta expression increased amount, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 4
from Danilova et al., 2018
|
whole organism tlr3 expression increased amount, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 2
from Danilova et al., 2018
|
whole organism irf3 expression increased amount, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 1
from Danilova et al., 2018
|
whole organism tnfa expression increased amount, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 3
from Danilova et al., 2018
|
head decreased size, abnormal
|
AB + MO2-rps19
|
standard conditions
|
Fig. 6
from Danilova et al., 2018
|
nucleate erythrocyte decreased amount, abnormal
|
WT + MO2-rps19
|
standard conditions
|
Fig. 3
from Danilova et al., 2014
Fig. 3
from Danilova et al., 2008
|
whole organism apoptotic, abnormal
|
WT + MO2-rps19
|
standard conditions
|
Fig. 2
from Danilova et al., 2008
|
forebrain aplastic, abnormal
|
WT + MO2-rps19
|
standard conditions
|
Fig. 2
from Danilova et al., 2008
|
eye aplastic, abnormal
|
WT + MO2-rps19
|
standard conditions
|
Fig. 2
from Danilova et al., 2008
|
heart malformed, abnormal
|
WT + MO2-rps19
|
chemical treatment by environment: metformin
|
Fig. 3
from Wilkes et al., 2020
|
whole organism decreased size, abnormal
|
WT + MO2-rps19
|
control
|
Fig. 4
from Bibikova et al., 2014
|
heart primordium position, abnormal
|
WT + MO2-rps19
|
standard conditions
|
Fig. 2
from Danilova et al., 2008
|
eye decreased size, abnormal
|
WT + MO2-rps19
|
standard conditions
|
Fig. 2
from Danilova et al., 2008
|
whole organism anterior-posterior axis kinked, abnormal
|
WT + MO2-rps19
|
control
|
Fig. 4
from Bibikova et al., 2014
|
eye hypoplastic, abnormal
|
WT + MO2-rps19
|
control
|
Fig. 4
from Bibikova et al., 2014
|
erythrocyte differentiation decreased occurrence, abnormal
|
WT + MO2-rps19
|
control
|
Fig. 4
from Bibikova et al., 2014
|
midbrain hindbrain boundary malformed, abnormal
|
WT + MO2-rps19
|
standard conditions
|
Fig. 2
from Danilova et al., 2008
|
blood apoptotic process increased process quality, abnormal
|
WT + MO2-rps19
|
standard conditions
|
Fig. 6
from Danilova et al., 2014
|
forebrain decreased size, abnormal
|
WT + MO2-rps19
|
standard conditions
|
Fig. 2
from Danilova et al., 2008
|
whole organism morphology, abnormal
|
WT + MO2-rps19
|
control
|
Fig. 4
from Bibikova et al., 2014
|
brain necrotic, abnormal
|
WT + MO2-rps19
|
standard conditions
|
Fig. 2
from Danilova et al., 2008
|
digestive system position, abnormal
|
WT + MO2-rps19
|
standard conditions
|
Fig. 2
from Danilova et al., 2008
|
whole organism hemoglobin amount, ameliorated
|
WT + MO2-rps19
|
chemical treatment by environment: metformin
|
Fig. 3
from Wilkes et al., 2020
|
erythrocyte development disrupted, abnormal
|
WT + MO2-rps19
|
standard conditions
|
Fig. 3
from Danilova et al., 2008
|
optic primordium decreased size, abnormal
|
WT + MO2-rps19
|
standard conditions
|
Fig. 2
from Danilova et al., 2008
|
whole organism anterior-posterior axis curved, abnormal
|
WT + MO2-rps19
|
control
|
Fig. 4
from Bibikova et al., 2014
|
head apoptotic process increased process quality, abnormal
|
WT + MO2-rps19
|
standard conditions
|
Fig. 6
from Danilova et al., 2014
|
whole organism ribosome decreased amount, abnormal
|
WT + MO2-rps19
|
standard conditions
|
Fig. 1
from Danilova et al., 2008
|
heart malformed, abnormal
|
WT + MO2-rps19
|
standard conditions
|
Fig. 3
from Wilkes et al., 2020
|
head decreased size, abnormal
|
WT + MO2-rps19
|
standard conditions
|
Fig. 2
from Danilova et al., 2008
|
cranial cartilage malformed, abnormal
|
WT + MO2-rps19
|
standard conditions
|
Fig. 2
from Danilova et al., 2008
|
whole organism hemoglobin decreased amount, abnormal
|
WT + MO2-rps19
|
standard conditions
|
Fig. 3
from Wilkes et al., 2020
|
intermediate cell mass of mesoderm erythroblast increased amount, abnormal
|
WT + MO2-rps19
|
standard conditions
|
Fig. 3
from Danilova et al., 2008
|
whole organism irf7 expression increased amount, abnormal
|
tp53zdf1/zdf1 + MO2-rps19
|
standard conditions
|
Fig. 1
from Danilova et al., 2018
|
whole organism c6.1 expression increased amount, abnormal
|
tp53zdf1/zdf1 + MO2-rps19
|
standard conditions
|
Fig. 5
from Danilova et al., 2018
|
whole organism tlr3 expression increased amount, abnormal
|
tp53zdf1/zdf1 + MO2-rps19
|
standard conditions
|
Fig. 2
from Danilova et al., 2018
|